Jeffrey Horowitz

Jeffrey Horowitz, MD

  • Pulmonary Disease
  • Critical Care Medicine
  • Physician

Professor of Internal Medicine

Accepting new patients
4.6 out of 5
  • 31 Patient Satisfaction Ratings
  • 13 Patient Comments

Insurances We Accept

About Me

As a pulmonary and critical care physician, my clinical practice is comprised of general outpatient and inpatient care for patients with acute or chronic lung disease and the care of patients in the medical intensive care units at The Ohio State University Wexner Medical Center. I also have an active research program focused on the cellular and molecular underpinnings of chronic fibrotic lung diseases such as Idiopathic Pulmonary Fibrosis with the long term goal of identifying novel therapeutic targets that will improve the lives of patients. I strive to communicate in a direct, honest and compassionate manner, to complete a thoughtful and reasoned diagnostic assessment and to partner with patients to determine the optimal therapies. Ultimately, my goal is to combine the best medical evidence with each patient’s goals and preferences to personalize the care of each patient.

Research interests: Mechanistic regulation of fibroblast survival and function by soluble and extracellular-matrix derived signaling during lung injury, repair and resolution, with a focus on how these mechanisms contribute to the pathogenesis of fibrotic lung diseases such as idiopathic pulmonary fibrosis (IPF).
Highlights
  • Division Director, Division of Pulmonary, Critical Care and Sleep Medicine (2020)
  • Research Funding from National Institutes of Health (2005-current)
  • Fellow of the American Thoracic Society (2018)
  • Editorial Board Member: The American Journal of Respiratory Cell and Molecular Biology (since 2017) and The American Journal of Pathology (since 2009)
  • Deputy Editor (2017-2019), Associate Editor (2016-2017) and Editorial Board Member (2019-present) of Respirology: the Official Journal of the Asian Pacific Respiratory Society
  • Sequence Director, M1 and M2 Respiratory Sequence (physiology and pathophysiology), University of Michigan Medical College (2015-2019)
  • Fellow of the American College of Chest Physicians (2008)
  • T. Franklin Williams Scholar of the Association of Specialty Professors (2008)
  • Recipient of the Dalsemer Award for Research in Interstitial Lung Disease from the American Lung Association (2006)
  • Medical Staff Award for Clinical Excellence, Rush Medical College (1998)
  • Alpha Omega Alpha, Rush Medical College (1998)
  • Phi Beta Kappa, Syracuse University (1993)

Procedures and Conditions I Treat

  • Intensive Care Units
  • Intensive Care
  • Emphysema
  • Pulmonary Fibrosis
  • Bronchitis, Chronic
  • Lung Diseases, Interstitial
  • Asthma
  • Lung Diseases
  • Pulmonary Medicine
  • Lung

Locations Where I Practice

Please note: Not all physicians schedule patients at each listed location.

Education and Training

Education History

Medical School

Rush Medical College of Rush Univ, Chicago, IL
MD
9/1/1994 - 6/1/1998

Internship

Rush Medical Center, Chicago, IL

7/1/1998 - 6/30/1999

Residency

Rush Medical Center, Chicago, IL

7/1/1999 - 6/30/2001

Fellowship

University of Michigan Hospitals, Ann Arbor, MI

7/1/2001 - 6/30/2004

Board Certification

American Board of Internal Medicine (Subspecialty: Pulmonary Disease)
11/5/2003

Academic Information

My Department

Internal Medicine

My Division

Pulmonary, Allergy, Critical Care and Sleep Medicine

Reviews

The overall patient satisfaction rating is an average of all patient responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page.

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of Ohio State Wexner Medical Center.

31 Patient Satisfaction Reviews

  • Overall
    4.6 out of 5
  • Explains Things Carefully
    4.7 out of 5
  • Listens Carefully
    4.5 out of 5
  • Gives Understandable Instructions
    4.6 out of 5
  • Knows My Medical History
    4.5 out of 5
  • Shows Respect
    4.5 out of 5
  • Time Spent Together
    4.7 out of 5
  • Reviewed on Apr 11, 2022

    All goid

  • Reviewed on Apr 04, 2022

    Very good.

  • Reviewed on Feb 27, 2022

    Efficient, easy personality, going forward to do test to determine my lung condition. Open to questions.

  • Reviewed on Jan 24, 2022

    Dr. Jeffrey Horowitz is an excellent pulmonologist. He explained everything to me in a simple word that I can understand thoroughly what's going on with my lungs.

  • Reviewed on Dec 19, 2021

    Excellent

  • Reviewed on Oct 26, 2021

    First time seeing/meeting Dr. Horowitz. He is a very pleasant person and doctor. He was familiar with my cancer treatment history at OSU and we made a plan of treatment and tests to determine any other action is needed.

  • Reviewed on Sep 16, 2021

    Excellent, can ask for a better staff to take care of me

  • Reviewed on Jun 19, 2021

    excellent

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 10/25/2021, Dr. Horowitz has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

  • United Therapeutics Corp.